Pharmaceuticals
The Word Is, 'Lexicon' Is Worth a Trade
Here's an options play on this small pharma name that just scored an FDA win.
Bristol-Myers Squibb Breaks a Key Support Area: What's Next?
Here's what the charts and indicators say.
Bearish Bets: 3 Stocks You Should Really Consider Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Debt Ceiling Games, Saudi Oil Warning, Covid Vaccine Stocks, Pressured Equities
New Covid infections appear to be surging in China due to the rise of the XBB sub-lineage of the Omicron variant.
Pfizer Stock Surges as Its Oral Weight-Loss Drug Challenges Ozempic
Here's what traders need to know.
Gilead Sciences Touches a Key Moving Average, So Is It Time to Buy?
It looks as though the answer could be yes as the shares of the biopharmaceutical company have built a nice base.
These 3 Global Drug Stocks Have a Prescription for High Yields
Let's review three pharma companies based outside the U.S. that promise reasonable valuations and solid dividend yields.
Lilly Has a Hot Obesity Drug: Here's How to Trade the Stock
On top of all the other best-selling drugs in the firm's stable, Mounjaro has game-changer type potential.
Take a Look Under the Microscope at These Two Biopharma Stocks
I've noticed that biotech has been one area of strength lately.
Vertex Pharmaceuticals Continues Its Impressive Rally: How to Play It
Buyers have been acting more aggressively than sellers.